3-(oxazolo[4,5-b]pyridin-2-yl)aniline | 52333-90-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-(oxazolo[4,5-b]pyridin-2-yl)aniline
• 英文别名: 3-oxazolo[4,5-b]pyridin-2-yl-aniline；2-(3-aminophenyl)oxazolo[4,5-b]pyridine；3-([1,3]oxazolo[4,5-b]pyridin-2-yl)aniline
• CAS: 52333-90-1
• 化学式: C₁₂H₉N₃O
• mdl: MFCD00606406
• 分子量: 211.223
• InChiKey: HKWQPWPKROMXCJ-UHFFFAOYSA-N

物化性质

• 溶解度：
  >31.7 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  64.9
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  3-(oxazolo[4,5-b]pyridin-2-yl)aniline 在 乙酸酐 作用下， 以 吡啶 为溶剂， 生成 N-(3-oxazolo[4,5-b]pyridin-2-yl-phenyl)-acetamide
  参考文献：
  名称：

  Anti-inflammatory oxazole[4,5-b]pyridines

  摘要：

  氧唑和噻唑吡啶的各种异构体，具有抗炎、退热和镇痛作用，通过将适当的氨基-羟基吡啶或氨基-巯基吡啶与羧酸、卤化物或酐进行缩合制备。

  公开号：

  US04038396A1
• 作为产物：
  描述：

  2-(3-Nntrophenyl)oxazolo[4,5-b]pyridine 在 钯 chloroform-petroleum ether 作用下， 以 乙醇 为溶剂， 以to give 2-(3-aminophenyl)oxazolo[4,5-b]pyridine, m.p. 179°-180.5° C.的产率得到3-(oxazolo[4,5-b]pyridin-2-yl)aniline
  参考文献：
  名称：

  Anti-inflammatory oxazolo [5,4-b]pyridines

  摘要：

  具有抗炎、退热和镇痛作用的氧唑烷和噻唑烷吡啶的各种异构体是通过将适当的氨基-羟基吡啶或氨基-巯基吡啶与羧酸、卤化物或酐缩合制备而成。

  公开号：

  US04131677A1

文献信息

• <i>N</i>-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
  作者：Naresh Sunduru、Mona Svensson、Mariateresa Cipriano、Sania Marwaha、C. David Andersson、Richard Svensson、Christopher J. Fowler、Mikael Elofsson

  DOI：10.1080/14756366.2016.1265520

  日期：2017.1.1

  Fatty acid amide hydrolase (FAAH) is a promising target for the development of drugs to treat neurological diseases. In search of new FAAH inhibitors, we identified 2-(4-cyclohexylphenoxy)-N-(3-(oxazolo[4,5-b]pyridin-2-yl)phenyl)acetamide, 4g, with an IC50 of 2.6 µM as a chemical starting point for the development of potent FAAH inhibitors. Preliminary hit-to-lead optimisation resulted in 2-(4-phe

  脂肪酸酰胺水解酶（FAAH）是开发用于治疗神经系统疾病的药物的有希望的目标。为了寻找新的FAAH抑制剂，我们确定了2g 2-（4-环己基苯氧基）-N-（3-（恶唑并[4,5-b]吡啶-2-基）苯基）乙酰胺，IC50为2.6 µM，开发有效的FAAH抑制剂的化学起点。初步的逐线优化得到2-i-（4-phenylphenoxy）-N-（3-（oxazolo [4,5-b] pyridin-2-yl）phenyl）乙酰胺4i，IC50为0.35 µM。
• Sirtuin modulating compounds
  申请人：Nunes J. Joseph

  公开号：US20070037809A1

  公开（公告）日：2007-02-15

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benfit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了新型的sirtuin调节化合物及其使用方法。这些sirtuin调节化合物可用于增加细胞寿命，并治疗和/或预防各种疾病和疾病，包括与衰老或应激有关的疾病或疾病，糖尿病，肥胖症，神经退行性疾病，心血管疾病，血液凝块性疾病，炎症，癌症和/或红斑病，以及需要增加线粒体活性的疾病或疾病。还提供了包含sirtuin调节化合物和另一种治疗剂的组合物。
• SIRTUIN MODULATING COMPOUNDS
  申请人：Nunes Joseph J.

  公开号：US20120197013A1

  公开（公告）日：2012-08-02

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了一种新颖的调节沉默信息调节因子（sirtuin）的化合物及其使用方法。这些调节sirtuin的化合物可用于延长细胞寿命，并用于治疗和/或预防多种疾病和障碍，包括与衰老或应激有关的疾病或障碍、糖尿病、肥胖症、神经退行性疾病、心血管疾病、血液凝结障碍、炎症、癌症和/或潮红，以及需要增加线粒体活性的疾病或障碍。还提供了包含sirtuin调节化合物与另一种治疗药物组合的组合物。
• N-Phenyl Benzamide Derivatives as Sirtuin Modulators
  申请人：Milburn Michael

  公开号：US20090163476A1

  公开（公告）日：2009-06-25

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了新型的调节sirtuin的化合物及其使用方法。这些sirtuin调节化合物可用于延长细胞寿命，以及治疗和/或预防各种疾病和障碍，包括与衰老或压力有关的疾病或障碍、糖尿病、肥胖症、神经退行性疾病、心血管疾病、血液凝结障碍、炎症、癌症和/或潮红，以及可以受益于增加线粒体活性的疾病或障碍。还提供了包含sirtuin调节化合物与另一种治疗剂的组合物。
• Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
  申请人：Sirtris Pharmaceuticals, Inc.

  公开号：EP2388263A1

  公开（公告）日：2011-11-23

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benfit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了新型sirtuin调节化合物及其使用方法。sirtuin调节化合物可用于延长细胞寿命，治疗和/或预防多种疾病和失调，包括与衰老或压力、糖尿病、肥胖症、神经退行性疾病、心血管疾病、凝血障碍、炎症、癌症和/或潮红有关的疾病或失调，以及可从线粒体活性增强中获益的疾病或失调。此外，还提供了由sirtuin调节化合物与另一种治疗剂组合而成的组合物。